Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients

Abstract Background The optimal treatment for locally advanced esophageal squamous cell carcinoma remains unclear. We compared the clinical outcomes of neoadjuvant concurrent chemoradiotherapy (CCRT) followed by esophagectomy [the surgery group] and CCRT without surgery [the CCRT group] in patients...

Full description

Bibliographic Details
Main Authors: Chih-Yi Chen, Chia-Chin Li, Chun-Ru Chien
Format: Article
Language:English
Published: BMC 2018-07-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12957-018-1444-0
id doaj-ece6257e44fc49d98c6a9e8afe8762a9
record_format Article
spelling doaj-ece6257e44fc49d98c6a9e8afe8762a92020-11-24T21:30:33ZengBMCWorld Journal of Surgical Oncology1477-78192018-07-011611810.1186/s12957-018-1444-0Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patientsChih-Yi Chen0Chia-Chin Li1Chun-Ru Chien2Division of Thoracic Surgery, Department of Surgery, Chung Shan Medical University, Chung Shan Medical University HospitalDepartment of Radiation Oncology, China Medical University HospitalDepartment of Radiation Oncology, China Medical University HospitalAbstract Background The optimal treatment for locally advanced esophageal squamous cell carcinoma remains unclear. We compared the clinical outcomes of neoadjuvant concurrent chemoradiotherapy (CCRT) followed by esophagectomy [the surgery group] and CCRT without surgery [the CCRT group] in patients with squamous cell carcinoma from an Asian population. Methods Eligible patients diagnosed from 2008 to 2015 were identified through the Taiwan Cancer Registry. To balance observable potential confounders, we constructed a 1:1 propensity score-matched cohort [surgery vs CCRT]. We compared the hazard ratios between the surgery and CCRT groups for death using a robust variance estimator. We also evaluated the outcomes of patients for freedom from local regional recurrence (FFLRR) and esophageal cancer-specific survival (ECSS). Extensive supplementary analyses were performed to examine the robustness of our findings. Results Our study population included 298 patients balanced with respect to the observed covariables. The hazard ratio of death was 0.56 [95% confidence interval 0.42~0.75] when surgery was compared to CCRT. The results remained significant in the FFLRR and ECSS outcomes. In the supplementary analyses, our results also remained significant when additional covariables were taken into consideration or when the definition of the index date was changed. Conclusions When compared to definitive CCRT, neoadjuvant CCRT followed by esophagectomy was associated with improved overall survival for locally advanced esophageal squamous cell carcinoma. However, given the nonrandomized nature of the study and the sensitivity to potentially unmeasured confounders, our results should be interpreted cautiously.http://link.springer.com/article/10.1186/s12957-018-1444-0Esophageal squamous cell carcinomaConcurrent chemoradiotherapyEsophagectomy
collection DOAJ
language English
format Article
sources DOAJ
author Chih-Yi Chen
Chia-Chin Li
Chun-Ru Chien
spellingShingle Chih-Yi Chen
Chia-Chin Li
Chun-Ru Chien
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
World Journal of Surgical Oncology
Esophageal squamous cell carcinoma
Concurrent chemoradiotherapy
Esophagectomy
author_facet Chih-Yi Chen
Chia-Chin Li
Chun-Ru Chien
author_sort Chih-Yi Chen
title Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
title_short Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
title_full Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
title_fullStr Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
title_full_unstemmed Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
title_sort neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
publisher BMC
series World Journal of Surgical Oncology
issn 1477-7819
publishDate 2018-07-01
description Abstract Background The optimal treatment for locally advanced esophageal squamous cell carcinoma remains unclear. We compared the clinical outcomes of neoadjuvant concurrent chemoradiotherapy (CCRT) followed by esophagectomy [the surgery group] and CCRT without surgery [the CCRT group] in patients with squamous cell carcinoma from an Asian population. Methods Eligible patients diagnosed from 2008 to 2015 were identified through the Taiwan Cancer Registry. To balance observable potential confounders, we constructed a 1:1 propensity score-matched cohort [surgery vs CCRT]. We compared the hazard ratios between the surgery and CCRT groups for death using a robust variance estimator. We also evaluated the outcomes of patients for freedom from local regional recurrence (FFLRR) and esophageal cancer-specific survival (ECSS). Extensive supplementary analyses were performed to examine the robustness of our findings. Results Our study population included 298 patients balanced with respect to the observed covariables. The hazard ratio of death was 0.56 [95% confidence interval 0.42~0.75] when surgery was compared to CCRT. The results remained significant in the FFLRR and ECSS outcomes. In the supplementary analyses, our results also remained significant when additional covariables were taken into consideration or when the definition of the index date was changed. Conclusions When compared to definitive CCRT, neoadjuvant CCRT followed by esophagectomy was associated with improved overall survival for locally advanced esophageal squamous cell carcinoma. However, given the nonrandomized nature of the study and the sensitivity to potentially unmeasured confounders, our results should be interpreted cautiously.
topic Esophageal squamous cell carcinoma
Concurrent chemoradiotherapy
Esophagectomy
url http://link.springer.com/article/10.1186/s12957-018-1444-0
work_keys_str_mv AT chihyichen neoadjuvantvsdefinitiveconcurrentchemoradiotherapyinlocallyadvancedesophagealsquamouscellcarcinomapatients
AT chiachinli neoadjuvantvsdefinitiveconcurrentchemoradiotherapyinlocallyadvancedesophagealsquamouscellcarcinomapatients
AT chunruchien neoadjuvantvsdefinitiveconcurrentchemoradiotherapyinlocallyadvancedesophagealsquamouscellcarcinomapatients
_version_ 1725962921681354752